Items Tagged ‘Tafinlar (dabrafenib)’

April 5, 2018

Tafinlar® + Mekinist® Demonstrates Long Term Survival Benefit for BRAF Mutation-Positive Metastatic Melanoma


CancerConnect News: Metastatic melanoma patients with the BRAF V600 mutation treated with the combination of Tafinlar® (dabrafenib) + Mekinist® (trametinib) can experience long term cancer free survival according to results presented at the 53rdAnnual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.1 About Melanoma  Metastatic melanoma refers to skin cancer that has spread from […]

View full entry

Tags: BRAF 600, Mekinist rametinib, Melanoma, Metastatic melanoma treatment, News, Precision Cancer Medicine, Skin Cancer, Tafinlar (dabrafenib)